BamSEC and AlphaSense Join Forces
Learn More

CTI BioPharma Corp

Formerly NASDAQ: CTIC
Search in Documents
Key Exhibits
External Links

Plans of Reorganization, Merger, Acquisition or Similar Filter

EX-2.1
from 8-K 96 pages Agreement and Plan of Merger Among: CTI BioPharma Corp., a Delaware Corporation; Swedish Orphan Biovitrum Ab (Publ), a Swedish Public Limited Liability Company; and Cleopatra Acquisition Corp., a Delaware Corporation Dated as of May 10, 2023
12/34/56
EX-2.1
from SC14D9C 96 pages Agreement and Plan of Merger Among: CTI BioPharma Corp., a Delaware Corporation; Swedish Orphan Biovitrum Ab (Publ), a Swedish Public Limited Liability Company; and Cleopatra Acquisition Corp., a Delaware Corporation Dated as of May 10, 2023
12/34/56
EX-2
from S-8 1 page [Letterhead of Gibson, Dunn & Crutcher Llp]
12/34/56
EX-2
from 8-K 2 pages CTI BioPharma Announces Closing of Rights Offering
12/34/56
EX-2
from 8-K 3 pages CTI BioPharma Announces Proposed Rights Offering Rights Offering Will Be Available to All Stockholders of Record on February 13, 2020 $60 Million Expected to Be Raised; Fully Backstopped by Bvf Partners L.P., Stonepine Capital, L.P., Orbimed Private Investments VI, LP, and New Enterprise Associates, Inc
12/34/56
EX-2.1
from 8-K 7 pages Agreement and Plan of Merger
12/34/56
EX-2.1
from 8-K/A 23 pages Dated 24 October 2014 Chroma Therapeutics Limited -And- CTI BioPharma Corp. Asset Purchase Agreement Relating to the Sale and Purchase of Certain Assets From Chroma Therapeutics Limited
12/34/56
EX-2.1
from 8-K 44 pages Purchase and Formation Agreement
12/34/56
EX-2.1
from 8-K 85 pages Acquisition Agreement Among Cell Therapeutics, Inc., Cactus Acquisition Corp., Saguaro Acquisition Company LLC, Systems Medicine, Inc. and Tom Hornaday and Lon Smith July 24, 2007
12/34/56
EX-2.5
from 8-K 13 pages CTI Stockholder Voting Agreement
12/34/56
EX-2.4
from 8-K 13 pages Form of CTI Stockholder Voting Agreement
12/34/56
EX-2.3
from 8-K 13 pages Form of Novuspharma Shareholder Voting Agreement
12/34/56
EX-2.2
from 8-K 13 pages Form of Novuspharma Shareholder Voting Agreement
12/34/56
EX-2.1
from 8-K 72 pages Agreement and Plan of Merger by and Between Cell Therapeutics, Inc. and Novuspharma, S.P.A. Dated as of June 16, 2003
12/34/56
EX-2.2
from 10-K ~5 pages Amendment No. 1 to Agreement and Plan of Reorganization
12/34/56
EX-2.1
from 8-K ~10 pages Agreement & Plan of Reorganization
12/34/56